Editorials
Preventing a covid-19 pandemic
BMJ 2020; 368 doi: https://doi.org/10.1136/bmj.m810 (Published 28 February 2020) Cite this as: BMJ 2020;368:m810Read our latest coverage of the Coronavirus outbreak
Related articles
- Editorial Published: 01 June 2021; BMJ 373 doi:10.1136/bmj.n1404
See more
- Covid-19: Pausing immune suppressing drugs enhances antibody response to boosters, study showsBMJ June 27, 2022, 377 o1586; DOI: https://doi.org/10.1136/bmj.o1586
- Could the use of digital services improve the provision of HIV PrEP in the UK?BMJ June 27, 2022, 377 o1562; DOI: https://doi.org/10.1136/bmj.o1562
- Polio’s detection in London is a wake-up callBMJ June 27, 2022, 377 o1589; DOI: https://doi.org/10.1136/bmj.o1589
- Overturning Roe v Wade: reproducing injusticeBMJ June 27, 2022, 377 o1588; DOI: https://doi.org/10.1136/bmj.o1588
- The impact of remote care on burden of treatmentBMJ June 27, 2022, 377 o1579; DOI: https://doi.org/10.1136/bmj.o1579
Cited by...
- Shining More Light on RAS Inhibition during the COVID-19 Pandemic
- Covid-19: Cummings, Johnson, Hancock, and a maelstrom of avoidable harm
- SARS-CoV-2 infection and adverse outcomes in users of ACE inhibitors and angiotensin-receptor blockers: a nationwide case-control and cohort analysis
- Determinants of COVID-19 outcomes: A systematic review
- Prospective meta-analysis protocol on randomised trials of renin-angiotensin system inhibitors in patients with COVID-19: an initiative of the International Society of Hypertension
- IN-HOSPITAL CONTINUATION WITH ANGIOTENSIN RECEPTOR BLOCKERS IS ASSOCIATED WITH A LOWER MORTALITY RATE THAN CONTINUATION WITH ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN COVID-19 PATIENTS: A RETROSPECTIVE COHORT STUDY
- Hospital Trainees Worries, Perceived Sufficiency of Information and Reported Psychological Health During The COVID-19 Pandemic
- Knowledge, Attitudes, and Fear of COVID-19 during the Rapid Rise Period in Bangladesh
- Does Lockdown Decrease the Protective Role of Ultraviolet-B (UVB) Radiation in Reducing COVID-19 Deaths?
- Evidence Supports a Causal Model for Vitamin D in COVID-19 Outcomes
- Association of Renin-Angiotensin-Aldosterone System Inhibition with Risk of COVID-19, Inflammation Level, Severity and Death in Patients With COVID-19: A Rapid Systematic Review and Meta-Analysis
- Evidence of Protective Role of Ultraviolet-B (UVB) Radiation in Reducing COVID-19 Deaths
- Analyses of abdominal adiposity and metabolic syndrome as risk factors for respiratory distress in COVID-19
- Robust ACE2 protein expression localizes to the motile cilia of the respiratory tract epithelia and is not increased by ACE inhibitors or angiotensin receptor blockers
- Distinguishing COVID-19 from influenza pneumonia in the early stage through CT imaging and clinical features
- Treatment with ACE-inhibitors is associated with less severe disease with SARS-Covid-19 infection in a multi-site UK acute Hospital Trust
- Management of Hemodialysis Patients with Suspected or Confirmed COVID-19 Infection: Perspective from the Spanish Nephrology
- Exploring the effectiveness of technology-based learning on the educational outcomes of undergraduate healthcare students: an overview of systematic reviews protocol
- Les inhibiteurs du systeme renine-angiotensinealdosterone et la COVID-19
- The renin-angiotensin system - a therapeutic target in COVID-19?
- Role of RNA Guanine Quadruplexes in Favoring the Dimerization of SARS Unique Domain in Coronaviruses
- Renin-angiotensin-aldosterone system inhibitors and COVID-19
- Sound Science before Quick Judgement Regarding RAS Blockade in COVID-19
- Will children reveal their secret? The coronavirus dilemma